You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | 0.0% | n/a |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -10.8 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 0.0 | 0.0 |
| Price / Book value | -109.3 |
| Latest | Forecast | |
|---|---|---|
| Revenue | n/a | 0.0% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | 22.2% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (€m) |
Pre-tax (€m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2016-12-31 | 0.95 | -10.06 | €-0.42 | -7.4 | 0.0 | n/a | n/a | 0.0% |
| 2017-12-31 | n/a | -21.06 | €-0.76 | -11.8 | 0.0 | n/a | n/a | 0.0% |
| 2018-12-31 | 0.02 | -20.08 | €-0.65 | -0.9 | 0.0 | n/a | n/a | 0.0% |
| 2019-12-31 | n/a | -13.25 | €-0.36 | -8.6 | 0.0 | n/a | n/a | 0.0% |
| 2020-12-31 | n/a | -16.94 | €-0.37 | -7.9 | 0.0 | n/a | n/a | 0.0% |
| Faron Pharmaceuticals signs US sublicence agreement Sharecast News | 14 May |
|---|---|
| FDA approves next two phases of Faron's Traumakine trial Sharecast News | 26 Jan |
| Faron gets Traumakine funding from US Department of Defense Sharecast News | 18 Jan |
| US rights to patent related to Traumakine | 14-May-21 07:01 |
|---|---|
| Holding(s) in Company | 10-May-21 14:30 |
| Grant of options | 29-Apr-21 12:45 |
| Board Change | 23-Apr-21 13:45 |
| Result of AGM | 23-Apr-21 13:45 |